2,050
Views
13
CrossRef citations to date
0
Altmetric
Commentary

Managing light chain deposition disease

Pages 183-184 | Published online: 05 Dec 2011

References

  • Minarik J, Scudla V, Tichy T, . Induction treatment of light chain deposition disease with bortezomib – rapid hematological response with persistence of renal involvement. Leuk Lymphoma 2011;53:330–331.
  • Gertz MA. Managing myeloma kidney. Ann Intern Med 2005;143: 835–837.
  • Ma CX, Lacy MQ, Rompala JF, . Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. Blood 2004;104:40–42.
  • Randall RE, Williamson WC, Jr., Mullinax F, . Manifestations of systemic light chain deposition. Am J Med 1976;60:293–299.
  • Preud'homme JL, Aucouturier P, Touchard G, . Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int 1994; 46:965–972.
  • Hotta O, Taguma Y. Resolution of nodular glomerular lesions in a patient with light-chain nephropathy. Nephron 2002;91:504–505.
  • Weichman K, Dember LM, Prokaeva T, . Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant 2006;38:339–343.
  • Telio D, Shepherd J, Forrest D, . High-dose melphalan followed by ASCT has favorable safety and efficacy in selected patients with light chain deposition disease and light and heavy chain deposition disease. Bone Marrow Transplant 2011.
  • Lorenz EC, Gertz MA, Fervenza FC, . Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Nephrol Dial Transplant 2008;23:2052–2057.
  • Kaposztas Z, Kahan BD, Katz SM, . Bortezomib Successfully Reverses Early Recurrence of Light-Chain Deposition Disease in a Renal Allograft: A Case Report. Transplant Proc 2009;41:4407–4410.
  • Kastritis E, Migkou M, Gavriatopoulou M, . Treatment of light chain deposition disease with bortezomib and dexamethasone. Haematologica 2009;94:300–302.
  • Short AK, O'Donoghue DJ, Riad HN, . Recurrence of light chain nephropathy in a renal allograft. A case report and review of the literature. Am J Nephrol 2001;21:237–240.
  • Leung N, Lager DJ, Gertz MA, Wilson K, Kanakiriya S, Fervenza FC. Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis 2004;43:147–153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.